Differences in risk-factor profiles between patients with ESBL-producing Escherichia coli and Klebsiella pneumoniae: A multicentre case-case comparison study

Antimicrobial Resistance and Infection Control

Volumn 3, Issue 1, 2014, Pages

  Freeman, Joshua T ^a,b   Rubin, Joseph ^c   McAuliffe, Gary N ^a   Peirano, Gisele ^c   Roberts, Sally A ^a,b   Drinković, Dragana ^d   Pitout, Johann D D ^c  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF CALGARY   (Canada)

^d WAITEMATA DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

Bacteraemia; ESBL; Escherichia coli; Klebsiella pneumoniae; Risk factors

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CASE STUDY; CHRONIC LUNG DISEASE; COMMUNITY ACQUIRED INFECTION; CONTROLLED STUDY; ESBL GENE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE SEPSIS; HOSPITAL ADMISSION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; NONHUMAN; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SPECIES COMPARISON;

EID: 84935022915     PISSN: None     EISSN: 20472994     Source Type: Journal    
DOI: 10.1186/2047-2994-3-27     Document Type: Article

References (32)

1. Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public health concern. Lancet Infect Dis 2008, 8:159-166. 10.1016/S1473-3099(08)70041-0, 18291338.
2. Cantón R, Coque TM. The CTX-M β-lactamase pandemic. Curr Opin Microbiol 2006, 9:466-475. 10.1016/j.mib.2006.08.011, 16942899.
3. Damjanova I, Tóth A, Pászti J, Hajbel-Vékony G, Jakab M, Berta J, Milch H, Füzi M. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005-the new 'MRSAs'?. J Antimicrob Chemother 2008, 62:978-985. 10.1093/jac/dkn287, 18667450.
4. Coelho A, Mirelis B, Alonso-Tarres C, Nieves Larrosa M, Miró E, Clivillé Abad R, Bartolomé RM, Castañer M, Prats G, Johnson JR, Navarro F, González-López JJ. Detection of three stable genetic clones of CTX-M-15-producing Klebsiella pneumoniae in the Barcelona metropolitan area, Spain. J Antimicrob Chemother 2009, 64:862-864. 10.1093/jac/dkp264, 19628471.
5. Pierano G, Hung King Sang J, Pitondo-silva A, Laupland KB, Pitout JD. Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae over a 10 year period in Calgary, Canada. J Antimicrob Chemother 2012, 67:1114-1120. 10.1093/jac/dks026, 22334607.
6. Park SY, Kang CI, Joo EJ, Ha YE, Wi YM, Chung DR, Peck KR, Lee NY, Song JH. Risk factors for multidrug resistance in nosocomial bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Microb Drug Resist 2012, 18:518-524. 10.1089/mdr.2012.0067, 22742454.
7. Freeman JT, McBride SJ, Nisbet MS, Gamble GD, Williamson DA, Taylor SL, Holland DJ. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes. Int J Infect Dis 2012, 16:371-374.
8. Ben Ami R, Schwaber MJ, Nanon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, Leavitt A, Carmeli Y. Influx of extended-spectrum β-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 2006, 42:925-934. 10.1086/500936, 16511754.
9. Hayakawa K, Gattu S, Marchaim D, Bhargava A, Palla M, Alshabani K, Gudur UM, Pulluru H, Bathina P, Sundaragiri PR, Sarkar M, Kakarlapudi H, Ramasamy B, Nanjireddy P, Mohin S, Dasagi M, Datla S, Kuchipudi V, Reddy S, Shahani S, Upputuri V, Marrey S, Gannamani V, Madhanagopal N, Annangi S, Sudha B, Muppavarapu KS, Moshos JA, Lephart PR, Pogue JM, et al. Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large US medical center. Antimicrob Agents Chemother 2013, 57:4010-4018. 10.1128/AAC.02516-12, 3719715, 23752516.
10. Kang CI, Wi YM, Lee MY, Ko KS, Chung DR, Peck KR, Lee NY, Song JH. Epidemiology and risk factors of community onset infections caused by extended-spectrum β-lactamase-producing Escherichia coli strains. J Clin Microbiol 2012, 50:312-317. 10.1128/JCM.06002-11, 3264158, 22162561.
11. Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, Kahlmeter G, Pan A, Petrosillo N, Rodríguez-Baño J, Singh N, Venditti M, Yokoe DS, Cookson B,. European Society of Clinical Microbiology ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 2014, 20(Suppl 1):1-55. European Society of Clinical Microbiology.
12. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002, 137:791-797. 10.7326/0003-4819-137-10-200211190-00007, 12435215.
13. Hsueh PR, Badal RE, Hawser SP, Hoban DJ, Bouchillon SK, Ni Y, Paterson DL,. 2008 Asia-Pacific SMART Group Epidemiology and antimicrobial susceptibility profiles of aerobic and facultative gram negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2008 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). Int J Antimicrob Agents 2010, 36:408-414. 10.1016/j.ijantimicag.2010.07.002, 20728316, 2008 Asia-Pacific SMART Group.
14. Abdul Rahman EM, El-Sherif RH. High rates of intestinal colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae among healthy individuals. J Investig Med 2011, 59:1284-1286.
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chron Dis 1987, 40:373-383. 10.1016/0021-9681(87)90171-8, 3558716.
16. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: nineteenth and twenty first informational supplements. 2009, M100-S19 and 2011:M100-S21. Wayne, PA: Clinical and Laboratory Standards Institute, Clinical and Laboratory Standards Institute.
17. Pitout JD, Gregson DB, Campbell L, Laupland KB. Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob Agents Chemother 2009, 53:2846-2851. 10.1128/AAC.00247-09, 2704701, 19380595.
18. Hunter SB, Vauterin P, Lambert-Fair MA, Van Duyne MS, Kubota K, Graves L, Wrigley D, Barrett T, Ribot E. Establishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: converting the national databases to the new size standard. J Clin Microbiol 2005, 43:1045-1050. 10.1128/JCM.43.3.1045-1050.2005, 1081233, 15750058.
19. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239. 228385, 7494007.
20. Heffernan HM, Woodhouse RE, Pope CE, Blackmore TK. Prevalence and types of extended-spectrum beta-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand. Int J Antimicrob Agents 2009, 34:544-549. 10.1016/j.ijantimicag.2009.07.014, 19748232.
21. Romero L, Lopez L, Rodreguez-bano J, Ramon Hernandez J, Martinez-Martinez L, Pascual A. Long term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases. Clin Microbiol Infect 2005, 11:625-631. 10.1111/j.1469-0691.2005.01194.x, 16008614.
22. Marcade G, Brisse S, Bialek S, Marcon E, Leflon-Guibout V, Passet V, Moreau R, Nicolas-Chanoine MH. The emergence of multidrug-resistant Klebsiella pneumoniae of international clones ST13, ST16, ST35, ST48 and ST101 in a teaching hospital in the Paris region. Epidemiol Infect 2013, 141:1705-1712. 10.1017/S0950268812002099, 23034125.
23. Ma L, Lu PL, Siu LK, Hsieh MH. Molecular typing and resistance mechanisms of imipenem-non-susceptible Klebsiella pneumoniae in Taiwan: results from the Taiwan surveillance of antibiotic resistance (TSAR) study, 2002-2009. J Med Microbiol 2013, 62:101-107. 10.1099/jmm.0.050492-0, 23002067.
24. Freeman JT, Williamson DA, Heffernan H, Smith M, Bower JE, Roberts SA. Comparative epidemiology of CTX-M-14 and CTX-M-15 producing Escherichia coli: Association with distinct demographic groups in the community in New Zealand. Eur J Clin Microbiol Infect Dis 2012, 31:2057-2060. 10.1007/s10096-011-1540-3, 22271302.
25. Nicolas Chanoine MH, Jarlier V, Robert J, Arlet G, Drieux L, Leflon-Guibout V, Laouénan C, Larroque B, Caro V, Mentré F,. Group Coli β Patient's origin and lifestyle associated with CTX-M-producing Escherichia coli: A case-control-control study. PLoS One 2012, 7:e30498. 10.1371/journal.pone.0030498, 3267726, 22299043, Group Coli β.
26. Harris AD, Kotetishvili M, Shurland S, Johnson JA, Morris JG, Nemoy LL, Johnson JK. How important is patient to patient transmission in extended-spectrum β-lactamase Escherichia coli acquisition. Am J Infect Control 2007, 35:97-101. 10.1016/j.ajic.2006.09.011, 17327188.
27. Harris AD, Perencevich EN, Johnson JK, Paterson DL, Morris JG, Strauss SM, Johnson JA. Patient to patient transmission is important in extended-spectrum β-lactamase producing Klebsiella pneumoniae acquisition. Clin Infect Dis 2007, 45:1347-1350. 10.1086/522657, 17968833.
28. Hilty M, Betsch BY, Bogli-Stuber K, Heiniger N, Stadler M, Küffer M, Kronenberg A, Rohrer C, Aebi S, Endimiani A, Droz S, Mühlemann K. Transmission dynamics of extended-spectrum β-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting. Clin Infect Dis 2012, 55:967-975. 10.1093/cid/cis581, 3436924, 22718774.
29. Cholley P, Thouverez M, Gbaugidi-Haore H, Sauget M, Slekovec C, Bertrand X, Talon D, Hocquet D. Hospital cross-transmission of extended-spectrum β-lactamase Escherichia coli and Klebsiella pneumoniae. Med Mal Infect 2013, 43:331-336. 10.1016/j.medmal.2013.06.001, 23876202.
30. Freeman JT, Nimmo J, Gregory E, Tiong A, De Almeida M, McAuliffe GN, Roberts SA. Predictors of hospital surface contamination with extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumonia: patient and organism factors. Antimicrob Resist Infect Control 2014, 4:3-5. doi:10.1186/2047-2994-3-5.
31. Moor CT, Roberts SA, Simmons G, Briggs S, Morris AJ, Smith J, Heffernan H. Extended-spectrum beta-lactamase enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand. J Hosp Infect 2008, 68:355-362. 10.1016/j.jhin.2008.02.003, 18353497.
32. Rodriguez-Bano J, Picon E, Gijon P, Hernández JR, Ruíz M, Peña C, Almela M, Almirante B, Grill F, Colomina J, Giménez M, Oliver A, Horcajada JP, Navarro G, Coloma A, Pascual A,. Spanish Network for Research in Infectious Diseases (REIPI) Community-Onset bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli: Risk Factors and Prognosis. Clin Infect Dis 2010, 50:40-48. 10.1086/649537, 19995215, Spanish Network for Research in Infectious Diseases (REIPI).